{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:22:47Z","timestamp":1780600967503,"version":"3.54.1"},"reference-count":8,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,19]]},"DOI":"10.1210\/endocr\/bqaf093","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T13:27:47Z","timestamp":1747315667000},"source":"Crossref","is-referenced-by-count":1,"title":["Ghrelin and LEAP2: Subtle Players in Cachexia, Essential for the Bigger Picture"],"prefix":"10.1210","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3833-4714","authenticated-orcid":false,"given":"Sarah H","family":"Lockie","sequence":"first","affiliation":[{"name":"Monash Biomedicine Discovery Institute and Department of Physiology, Monash University , Clayton, Victoria 3800 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7951-743X","authenticated-orcid":false,"given":"Adam","family":"Hagg","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, University of Queensland , St Lucia, Queensland 4067 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"4","key":"2025060301512661900_bqaf093-B1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"issue":"11","key":"2025060301512661900_bqaf093-B2","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae132","article-title":"The LEAP2 response to cancer-related anorexia-cachexia syndrome in male mice and patients","volume":"165","author":"Varshney","year":"2024","journal-title":"Endocrinology"},{"issue":"1","key":"2025060301512661900_bqaf093-B3","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/s41467-022-32135-0","article-title":"Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer","volume":"13","author":"Queiroz","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"2025060301512661900_bqaf093-B4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13539-011-0043-5","article-title":"Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia","volume":"2","author":"Trobec","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"2025060301512661900_bqaf093-B5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00520-016-3560-0","article-title":"Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis","volume":"25","author":"Bai","year":"2017","journal-title":"Support Care Cancer"},{"key":"2025060301512661900_bqaf093-B6","doi-asserted-by":"crossref","first-page":"101950","DOI":"10.1016\/j.molmet.2024.101950","article-title":"A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice","volume":"84","author":"Shankar","year":"2024","journal-title":"Mol Metab"},{"issue":"5","key":"2025060301512661900_bqaf093-B7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"22","key":"2025060301512661900_bqaf093-B8","doi-asserted-by":"crossref","first-page":"17942","DOI":"10.1074\/jbc.M112.358051","article-title":"Profound hypoglycemia in starved, ghrelin-deficient mice is caused by decreased gluconeogenesis and reversed by lactate or fatty acids","volume":"287","author":"Li","year":"2012","journal-title":"J Biol Chem"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqaf093\/63194266\/bqaf093.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/166\/7\/bqaf093\/63194266\/bqaf093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/166\/7\/bqaf093\/63194266\/bqaf093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:51:37Z","timestamp":1748929897000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqaf093\/8132831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,5,19]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqaf093","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,15]]},"article-number":"bqaf093"}}